Cargando…

Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy

BACKGROUND: The use of circulating cDC1 to generate anti-cancer vaccines is among the most promising approaches to overcome the limited immunogenicity and clinical efficacy of monocyte-derived DC. However, the recurrent lymphopenia and the reduction of DC numbers and functionality in patients with c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mastelic-Gavillet, Beatris, Sarivalasis, Apostolos, Lozano, Leyder Elena, Lofek, Sebastien, Wyss, Tania, Melero, Ignacio, de Vries, I. Jolanda M., Harari, Alexandre, Romero, Pedro, Kandalaft, Lana Elias, Viganó, Selena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950108/ https://www.ncbi.nlm.nih.gov/pubmed/36845155 http://dx.doi.org/10.3389/fimmu.2023.1119371

Ejemplares similares

Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer
por: Ahmed, Ritaparna, et al.
Publicado: (2023)

Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results
por: Mastelic-Gavillet, Beatris, et al.
Publicado: (2019)

Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8(+) T cells
por: Mastelic-Gavillet, Beatris, et al.
Publicado: (2019)

A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma
por: Sarivalasis, Apostolos, et al.
Publicado: (2019)

Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human
por: Chiang, Cheryl Lai-Lai, et al.
Publicado: (2021)

Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets
por: Wimmers, Florian, et al.
Publicado: (2014)

A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner
por: Auderset, Floriane, et al.
Publicado: (2020)

A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma
por: Harari, Alexandre, et al.
Publicado: (2021)

Vaccines as Priming Tools for T Cell Therapy for Epithelial Cancers
por: Kandalaft, Lana E., et al.
Publicado: (2021)

Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites
por: Wefers, Christina, et al.
Publicado: (2019)

The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
por: Bol, Kalijn F., et al.
Publicado: (2019)

Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?
por: Martin Lluesma, Silvia, et al.
Publicado: (2018)

Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets?
por: Huber, Anne, et al.
Publicado: (2018)

The era of bioengineering: how will this affect the next generation of cancer immunotherapy?
por: Graciotti, Michele, et al.
Publicado: (2017)

Neonatal T Follicular Helper Cells Are Lodged in a Pre-T Follicular Helper Stage Favoring Innate Over Adaptive Germinal Center Responses
por: Mastelic-Gavillet, Beatris, et al.
Publicado: (2019)

Cancer Vaccines in Ovarian Cancer: How Can We Improve?
por: Martin Lluesma, Silvia, et al.
Publicado: (2016)

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
por: Laureano, Raquel S, et al.
Publicado: (2022)

Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors
por: Yakkala, Chakradhar, et al.
Publicado: (2019)

High reliability DC/DC converter module for electronic boards equipped with FPGAs
por: Vigano, William, et al.
Publicado: (2015)

Disruption of IL-21 Signaling Affects T Cell-B Cell Interactions and Abrogates Protective Humoral Immunity to Malaria
por: Pérez-Mazliah, Damián, et al.
Publicado: (2015)

The real thing: How to make human DC subsets
por: Geissmann, Frederic
Publicado: (2015)

Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure
por: Vigano, Selena, et al.
Publicado: (2020)

Paraneoplastic Cerebellar Ataxia Can Affect Prognosis in High-Grade Serous Ovarian Cancer: A Case Report
por: Liapi, Aikaterini, et al.
Publicado: (2020)

Distinct DC subsets are not equally susceptible to HTLV-1 infection
por: Alais, Sandrine, et al.
Publicado: (2014)

DC-Based Vaccines for Cancer Immunotherapy
por: Fu, Chunmei, et al.
Publicado: (2020)

DC-Derived Exosomes for Cancer Immunotherapy
por: Yao, Yi, et al.
Publicado: (2021)

DC-targeting lentivectors for cancer immunotherapy
por: Gea-Mallorquí, Ester, et al.
Publicado: (2023)

Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity
por: Tsoutsou, Pelagia G., et al.
Publicado: (2018)

Functional Avidity: A Measure to Predict the Efficacy of Effector T Cells?
por: Viganò, Selena, et al.
Publicado: (2012)

Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan
por: Vono, Maria, et al.
Publicado: (2018)

Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation
por: Auderset, Floriane, et al.
Publicado: (2019)

Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
por: Vigano, Selena, et al.
Publicado: (2019)

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
por: Herrera, Fernanda G., et al.
Publicado: (2022)

Dynamic changes of DC and T cell subsets in mice during Echinococcus multilocularis infection
por: Wei, Xiao-li, et al.
Publicado: (2014)

Believe in yourself, and enjoy the ride
por: Kandalaft, Lana E.
Publicado: (2019)

Assessing the Role of STAT3 in DC Differentiation and Autologous DC Immunotherapy in Mouse Models of GBM
por: Assi, Hikmat, et al.
Publicado: (2014)

Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response
por: Basit, Farhan, et al.
Publicado: (2018)

DC-based immunotherapy as strategy to purge the HIV reservoir?
por: Søgaard, Ole S.
Publicado: (2019)

Dual first-line maintenance by PARP inhibitor and bevacizumab can cause confusion in high-grade serous ovarian cancer: A case of PRES and a review of the literature
por: Liapi, Aikaterini, et al.
Publicado: (2023)

Recent Advances and Future Perspective of DC-Based Therapy in NSCLC
por: van der Hoorn, Iris A. E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r3818i84cvv7mt7usqiftqqb26